Alphatec Spine to Showcase Product Portfolio at EuroSpine 2013 in Liverpool, UK

Alphatec Spine to Showcase Product Portfolio at EuroSpine 2013 in Liverpool,
UK

CARLSBAD, Calif., Sept. 25, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that provides physician-inspired solutions for patients with spinal
disorders, announced today that it will showcase its product portfolio at the
upcoming EuroSpine 2013 meeting, which is being held in Liverpool, UK, from
October 2^nd to 4^th, 2013. Alphatec Spine will be located in booth number
A21. The EuroSpine annual meeting is an important venue in Europe for sharing
research, knowledge and innovation in the prevention and treatment of spinal
disorders.

This year Alphatec Spine will be showcasing key products from all of its major
portfolio segments including, MIS, Degenerative, Deformity, Interbody,
Cervical and Biologics. Products to be focused on in Alphatec Spine's booth
and workshop will include the ILLICO® Multi-Level MIS system, the Alphatec
Solus® ALIF cage, the Epicage® MIS interbody device, and the Zodiac® DVR
(Direct Vertebral Rotation) Deformity system. Additionally, the Company will
also be highlighting several of its and Scient'x S.A.S.'s products that have
CE clearance, including the DiscoCerv® artificial disc, the Isobar™ Evolution
dynamic rod, the PCB Evolution interbody device and the HeliFix® interspinous
process device, among others.

"We are excited to participate in EuroSpine 2013 and to discuss the breadth of
our product portfolio, while exchanging ideas and best practices around key
spinal topics that affect the lives of the patients we serve," said Les Cross,
Chairman and CEO of Alphatec Spine, Inc. "Continuing to grow and support our
international business is a key component of our corporate strategy. EuroSpine
2013 provides a forum where we can connect with existing and potential
international customers and demonstrate the unique benefits and value of our
complementary product suite. We are proud to play a significant role in
helping patients around the world regain their active lifestyles."

In addition, on Friday, October 4th at 12:00pm in Room number 4A, Alphatec
Spine will be hosting a workshop entitled, "Advanced MIS and Open Techniques
in Deformity Correction", featuring presentations and facilitation by key
thought leaders in spinal surgery: Dr. Masood Shafafy, QMC Nottingham, UK and
Dr. Robert Lee, RNOH Stanmore, UK.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
physician-inspired products and solutions for the treatment of spinal
disorders associated with trauma, congenital deformities, disease and
degeneration. The Company's mission is to combine innovative surgical
solutions with world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors.

Additional information can be found at www.alphatecspine.com.

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no assurance
that actual results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as a result of
various factors. Forward-looking statements include references to the
Company's belief that certain of its products offer competitive
functionalities in the marketplace. The words "believe," "will," "should,"
"expect," "intend," "estimate" and "anticipate," variations of such words and
similar expressions identify forward-looking statements, but their absence
does not mean that a statement is not a forward-looking statement. The
important factors that could cause actual operating results to differ
significantly from those expressed or implied by such forward-looking
statements include, but are not limited to: Alphatec Spine's ability to
continue to grow and support its international business; the uncertainty of
success in developing or acquiring and commercializing new products or product
technologies; acceptance of Alphatec Spine's and its affiliate's products by
the international surgeon community, including without limitation the products
discussed in this press release; Alphatec Spine's ability to develop and
expand its U.S. and/or global revenues; continuation of favorable third part
payor reimbursement for procedures performed using Alphatec Spine's products;
unanticipated expenses or liabilities or other adverse events affecting cash
flow or Alphatec Spine's ability to successfully control its costs or achieve
profitability; uncertainty of additional funding; Alphatec Spine's ability to
compete with other competing products and with emerging new technologies;
product liability exposure; patent infringement claims and claims related to
Alphatec Spine's intellectual property. Please refer to the risks detailed
from time to time in Alphatec Spine's SEC reports, including its Annual Report
Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form
8-K. Alphatec Spine disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information, future
events, or otherwise, unless required by law.

CONTACT: Investor/Media Contact:
        
         Christine Zedelmayer
         Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610
         czedelmayer@alphatecspine.com

Alphatec Spine